About
Continuously achieved YTD of Above 110% in year 2020,2021 respectively also achieved the award of best selling new launched product unit wise in my territory, Joined Novo Nordisk and completed basecap training, also launched reasearch molecule (Semaglutide) by the name of Ozempic for the managemnt of Type 2 Diabetes, specially focused on Endocrinology Specialty.
Experience
Medical Sales Officer
Sami pharmaceuticals
2020 — 2022
Product Specialist
Novo Nordisk
2022 — Present
Education
Pharm-D
University Of Peshawar
2015 — 2020